Skip to main content
Clinical Trials/NCT01746329
NCT01746329CompletedNot Applicable

Exploratory Study on the Effect of Nutritional Intervention on Postprandial Skeletal Muscle Microcirculation in Obese Subjects

Unilever R&D2 sites in 1 country18 target enrollmentStarted: December 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
18
Locations
2
Primary Endpoint
Vascular resistance

Study Overview

Brief Summary

In the present study, muscle perfusion will be studied before and after an oral glucose challenge following a fasting period.

Detailed Description

Based on data from previous studies, this physiological response is blunted in obese subjects, and the investigators expect these responses to be restored when the glucose load is combined with tea or beetroot juice in obese, insulin resistant men.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
30 Years to 70 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Aged 30-70 years.
  • Obesity (BMI>30 kg/m2)
  • insulin resistance as fasting glucose levels >6.1 mmol/L.
  • Reported intense sport activities >10 h/w.
  • Reported alcohol consumption >28 units/w
  • Signed Informed consent
  • Currently not smoking and being a non-smoker for at least 3 months prior to the start of the study.

Exclusion Criteria

  • BMI ≥ 40 kg/m
  • Presence of cardiovascular disease.
  • Presence of sudden cardiac death in a 1st degree relative at an age <50 years.
  • Presence of diabetes mellitus type
  • Regular tea drinker (> 2 cups per day)

Outcomes

Primary Outcomes

Vascular resistance

Time Frame: Average of values obtained at 30, 60, 90, 120, 150 and 180 minutes after test product intake corrected for the value obtained at approximately 20 minutes before test product intake (baseline)

Vascular resistance (arm and leg) as obtained from venous occlusion plethysmography and corrected for blood pressure

Secondary Outcomes

  • echo-Doppler(Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake)
  • Near-infrared spectroscopy(Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake)
  • Glucose and insulin(Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake)
  • Vascular resistance exploratory(Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake)

Investigators

Sponsor
Unilever R&D
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials